Moving forward in hidradenitis suppurativa lesion definitions and counts.
作者信息
van Straalen K R, Thorlacius L
机构信息
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
出版信息
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):23-24. doi: 10.1111/jdv.20453.
Abstract
摘要
相似文献
1
Moving forward in hidradenitis suppurativa lesion definitions and counts.在化脓性汗腺炎病变的定义和计数方面取得进展。
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):23-24. doi: 10.1111/jdv.20453.
2
Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.化脓性汗腺炎临床反应在化脓性汗腺炎患者评估中的可靠性
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2254-2256. doi: 10.1111/jdv.15163. Epub 2018 Jul 17.
3
Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design.量化未经治疗的化脓性汗腺炎患者皮损计数随时间的自然变化：对疗效指标和试验设计的意义。
JAAD Int. 2020 Nov 7;1(2):208-221. doi: 10.1016/j.jdin.2020.09.005. eCollection 2020 Dec.
4
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.IHS4 - 55的开发与验证，这是一种用于评估化脓性汗腺炎治疗效果的IHS4二分结果。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):395-401. doi: 10.1111/jdv.18632. Epub 2022 Oct 19.
5
Gluteal hidradenitis suppurativa presenting pemphigus-like findings: case report.表现为类天疱疮样表现的化脓性汗腺炎：病例报告
BMC Dermatol. 2019 Jul 23;19(1):11. doi: 10.1186/s12895-019-0091-7.
6
Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections.阿达木单抗、甲氨蝶呤及皮损内注射糖皮质激素有效维持治疗化脓性汗腺炎伴滑膜炎、痤疮、脓疱病、骨肥厚和骨炎综合征。
SAGE Open Med Case Rep. 2018 Jun 1;6:2050313X18778723. doi: 10.1177/2050313X18778723. eCollection 2018.
7
Pediatric-onset hidradenitis suppurativa: a case series of 42 patients.儿童期发病的化脓性汗腺炎：42例病例系列
Postepy Dermatol Alergol. 2024 Oct;41(5):525-529. doi: 10.5114/ada.2024.144517. Epub 2024 Oct 28.
8
Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn's Disease?化脓性汗腺炎作为克罗恩病患者使用阿达木单抗的一种矛盾的副作用？
Clin Exp Gastroenterol. 2020 Aug 19;13:293-298. doi: 10.2147/CEG.S263685. eCollection 2020.
9
Verrucous carcinoma arising in hidradenitis suppurativa.发生于化脓性汗腺炎的疣状癌。
Int J Colorectal Dis. 2000 Nov;15(5-6):342-6. doi: 10.1007/s003840000256.
10
Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence.自动国际化脓性汗腺炎严重程度评分系统 (AIHS4)：一种使用人工智能评估化脓性汗腺炎严重程度的新工具。
Skin Res Technol. 2023 Jun;29(6):e13357. doi: 10.1111/srt.13357.
本文引用的文献
1
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.医疗服务提供者和患者对化脓性汗腺炎病变特征的认知差异。
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):210-220. doi: 10.1111/jdv.19999. Epub 2024 Apr 10.
2
Severity rating of specific skin lesions in hidradenitis suppurativa: the ptient perspective.化脓性汗腺炎特定皮肤损害的严重程度分级：患者视角
Br J Dermatol. 2024 Mar 15;190(4):579-581. doi: 10.1093/bjd/ljad491.
3
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.化脓性汗腺炎结局评估工具和分期系统的评价者间信度和可靠性。
Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.
4
Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.患有化脓性汗腺炎的患者中寻常痤疮的总体患病率和亚组患病率。
J Am Acad Dermatol. 2019 May;80(5):1308-1313. doi: 10.1016/j.jaad.2018.09.040. Epub 2018 Oct 1.
5
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.化脓性汗腺炎临床试验结局的核心领域集：一项国际 Delphi 研究。
Br J Dermatol. 2018 Sep;179(3):642-650. doi: 10.1111/bjd.16672. Epub 2018 Jul 5.
Zotero 插件